In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
July 24th, 2004 | 33 | No |
Popular Name: Glyburide Glyburide
Find On: PubMed — Wikipedia — Google
CAS Numbers: 10238-21-8 , 23047-14-5 , [10238-21-8]
1-((p-(2-(5-Chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea
1-(p-(2-(5-Chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea
10238-21-8; C07022; Glibenclamide; Glyburide
10238-21-8; CPD000058229; Glyburide; SAM002564212
10238-21-8; Glibenclamide; Prestwick_569
5-chloro-N-(2-{4-[(cyclohexylcarbamoyl)aminosulfonyl]phenyl}ethyl)-2-methoxybenzamide
5-chloro-N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)phenethyl)-2-methoxybenzamide
5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide
5-Chloro-N-[2-[4-[[[(cyclohexylamino)carbonyl]-amino]sulfonyl]phenyl]-ethyl]-2-methoxybenzamide
5-Chloro-N-[4-(cyclohexylureidosulfonyl)phenethyl]-2-methoxybenzamide
Apo-Glibenclamide;Glibenclamida [INN-Spanish];Glibenclamide;Glibenclamidum [INN-Latin]
C23H28ClN3O5S.C4H11N5.Cl; GLUCOVANCE; GLYBURIDE; METFORMIN HYDROCHLORIDE; LS-178556
CPD000058229; Glybenclamide; Glyburide; SAM002564212
glibenclamida; glibenclamide; glibenclamidum
Glibenclamide, Glycron, Glynase, Micronase, Daonil, Semi-Daonil, Euglucon, Delmide
Glibenclamidum [INN-Latin];Glibenclamida [INN-Spanish];Glibenclamide;Apo-Glibenclamide
N-(4-(2-(5-Chloro-2-methoxybenzamido)ethyl)phenylsulfonyl)-N'-cyclohexylurea
N-p-[2-(5-Chloro-2-methoxybenzamido)-ethyl]benzene-sulfonyl-N -cyclohexylurea
N-p-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzenesulfonyl-N'-cyclohexylurea
N1-[4-({[(cyclohexylamino)carbonyl]amino}sulfonyl)phenethyl]-5-chloro-2-methoxybenzamide
Urea, 1-((p-(2-(chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexyl-
Urea, 1-(p-(2-(5-chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexyl-
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 4.40 | 5.51 | -67.24 | 2 | 8 | -1 | 120 | 493.005 | 9 | ↓ |
Ref Reference (pH 7) | 4.40 | 4.95 | -23.65 | 3 | 8 | 0 | 117 | 494.013 | 9 | ↓ |
Lo Low (pH 4.5-6) | 4.77 | 7.45 | -21.59 | 3 | 8 | 0 | 114 | 494.013 | 8 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Melting_Point | 171-174? | Alfa-Aesar |
Melting_Point | 171-174° | Alfa-Aesar |
ALOGPS_SOLUBILITY | 2.06e-03 g/l | DrugBank-approved |
Purity | >99% | Fluorochem |
UniProt Database Links | AB5C_ARATH; CISD1_HUMAN; TRPM4_MOUSE | ChEBI |
Therapy | Antidiabetic agent which blocks pancreatic ATP-dependent K+ channels resulting in an increase in intracellular Ca2+ and | SMDC Iconix |
biological_use | Antidiabetic drug (type II diabetes) | IBScreen Bioactives |
therap | antihyperglycemic | MicroSource Spectrum |
mechanism | ATP-sensitive potassium channels | ZereneX Building Blocks |
mechanism | ATP-sensitive potassium channels (KATP) blocker in pancreatic beta cells | IBScreen Bioactives |
Patent Database Links | EP1201649; EP1201660; EP1354882; EP1493443; EP1514550; EP1559710; EP1611879; EP1629835; EP1741713; EP1743655; EP1785144; EP1808163; EP1832291; EP1832576; EP1862450; EP1884244; EP1894567; EP1897547; EP1939188; EP1946777; EP1972336; EP1997489; EP1997533; US | ChEBI |
biological_use | Inhibits drug-induced coronary vasodilation | IBScreen Bioactives IBScreen Bioactives |
biological_use | Inhibits drug-induced coronary vasodilation; Antidiabetic drug | ZereneX Building Blocks |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : G-2693; NCC_SUPPLIER_SAMPLE_COMMENTS : WHITE POWDER | NIH Clinical Collection via PubChem |
Target | Others | Selleck Chemicals |
Target | Potassium Channel | Selleck Chemicals |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: G-2693; SUPPLIER_COMMENTS: WHITE POWDER | NIH Clinical Collection via PubChem |
Indications | type II diabetes | KeyOrganics Bioactives |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AMPC-2-B | Beta-lactamase (cluster #2 Of 6), Bacterial | Bacteria | 49 | 0.31 | Binding ≤ 10μM |
ABCC8-1-E | Sulfonylurea Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4 | 0.36 | Binding ≤ 10μM |
ABCC9-1-E | Sulfonylurea Receptor 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1 | 0.38 | Binding ≤ 10μM |
CTRA-3-E | Alpha-chymotrypsin (cluster #3 Of 4), Eukaryotic | Eukaryotes | 8 | 0.34 | Binding ≤ 10μM |
IRK11-1-E | Potassium Channel, Inwardly Rectifying, Subfamily J, Member 11 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 4 | 0.36 | Binding ≤ 10μM |
IRK8-1-E | Potassium Channel, Inwardly Rectifying, Subfamily J, Member 8 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.38 | Binding ≤ 10μM |
KCND3-1-E | Voltage-gated Potassium Channel Subunit Kv4.3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.38 | Binding ≤ 10μM |
MDHM-1-E | Malate Dehydrogenase, Mitochondrial (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3 | 0.36 | Binding ≤ 10μM |
Z50512-1-O | Cavia Porcellus (cluster #1 Of 7), Other | Other | 8 | 0.34 | Functional ≤ 10μM |
Z50597-1-O | Rattus Norvegicus (cluster #1 Of 12), Other | Other | 2 | 0.37 | Functional ≤ 10μM |
Z81047-1-O | Human T-cell Line (cluster #1 Of 2), Other | Other | 1000 | 0.25 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CTRA_BOVIN | P00766 | Alpha-chymotrypsin, Bovin | 6 | 0.35 | Binding ≤ 1μM |
AMPC_ENTCL | P05364 | Beta-lactamase, Entcl | 49 | 0.31 | Binding ≤ 1μM |
AMPC_ECOLI | P00811 | Beta-lactamase, Ecoli | 5 | 0.35 | Binding ≤ 1μM |
MDHM_PIG | P00346 | Malate Dehydrogenase Mitochondrial, Pig | 24 | 0.32 | Binding ≤ 1μM |
IRK11_HUMAN | Q14654 | Potassium Channel, Inwardly Rectifying, Subfamily J, Member 11, Human | 130 | 0.29 | Binding ≤ 1μM |
IRK11_RAT | P70673 | Potassium Channel, Inwardly Rectifying, Subfamily J, Member 11, Rat | 0.608 | 0.39 | Binding ≤ 1μM |
IRK8_RAT | Q63664 | Potassium Channel, Inwardly Rectifying, Subfamily J, Member 8, Rat | 0.608 | 0.39 | Binding ≤ 1μM |
ABCC8_HUMAN | Q09428 | Sulfonylurea Receptor 1, Human | 4.3 | 0.35 | Binding ≤ 1μM |
ABCC9_HUMAN | O60706 | Sulfonylurea Receptor 2, Human | 130 | 0.29 | Binding ≤ 1μM |
ABCC9_RAT | Q63563 | Sulfonylurea Receptor 2, Rat | 0.608 | 0.39 | Binding ≤ 1μM |
KCND3_HUMAN | Q9UK17 | Voltage-gated Potassium Channel Subunit Kv4.3, Human | 0.608 | 0.39 | Binding ≤ 1μM |
CTRA_BOVIN | P00766 | Alpha-chymotrypsin, Bovin | 6 | 0.35 | Binding ≤ 10μM |
AMPC_ENTCL | P05364 | Beta-lactamase, Entcl | 49 | 0.31 | Binding ≤ 10μM |
AMPC_ECOLI | P00811 | Beta-lactamase, Ecoli | 5 | 0.35 | Binding ≤ 10μM |
MDHM_PIG | P00346 | Malate Dehydrogenase Mitochondrial, Pig | 24 | 0.32 | Binding ≤ 10μM |
IRK11_HUMAN | Q14654 | Potassium Channel, Inwardly Rectifying, Subfamily J, Member 11, Human | 130 | 0.29 | Binding ≤ 10μM |
IRK11_RAT | P70673 | Potassium Channel, Inwardly Rectifying, Subfamily J, Member 11, Rat | 0.608 | 0.39 | Binding ≤ 10μM |
IRK8_RAT | Q63664 | Potassium Channel, Inwardly Rectifying, Subfamily J, Member 8, Rat | 0.608 | 0.39 | Binding ≤ 10μM |
ABCC8_HUMAN | Q09428 | Sulfonylurea Receptor 1, Human | 4.3 | 0.35 | Binding ≤ 10μM |
ABCC9_RAT | Q63563 | Sulfonylurea Receptor 2, Rat | 0.608 | 0.39 | Binding ≤ 10μM |
ABCC9_HUMAN | O60706 | Sulfonylurea Receptor 2, Human | 130 | 0.29 | Binding ≤ 10μM |
KCND3_HUMAN | Q9UK17 | Voltage-gated Potassium Channel Subunit Kv4.3, Human | 0.608 | 0.39 | Binding ≤ 10μM |
Z50512 | Z50512 | Cavia Porcellus | 8 | 0.34 | Functional ≤ 10μM |
Z81047 | Z81047 | Human T-cell Line | 1000 | 0.25 | Functional ≤ 10μM |
Z50597 | Z50597 | Rattus Norvegicus | 1.6 | 0.37 | Functional ≤ 10μM |
Description | Species |
---|---|
ABC-family proteins mediated transport | |
ATP sensitive Potassium channels | |
Regulation of insulin secretion | |
Voltage gated Potassium channels |